Literature DB >> 17882153

Risk of intracranial aneurysm bleeding in autosomal-dominant polycystic kidney disease.

T Ring1, D Spiegelhalter.   

Abstract

Patients with autosomal-dominant polycystic kidney disease (ADPKD) carry an increased risk of developing intracranial aneurysms. Bleeding from these sites is a significant complication with the events reported to cluster in some families. In this study we determined if individualized risk of aneurysm rupture can be estimated based on family history using a Bayesian random effects model. Previously reported data were used to define distributions and to construct a model that fit these data. Our results confirm that intracerebral aneurysm bleeding in ADPKD patients tends to cluster in families and that basic family history can provide a simple estimate of family-specific risk.

Entities:  

Mesh:

Year:  2007        PMID: 17882153     DOI: 10.1038/sj.ki.5002488

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  13 in total

1.  Treatment of Unruptured Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease: Primum Non Nocere.

Authors:  M Niemczyk
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-15       Impact factor: 3.825

2.  Autosomal dominant inheritance of a predisposition to thoracic aortic aneurysms and dissections and intracranial saccular aneurysms.

Authors:  Ellen Regalado; Sarah Medrek; Van Tran-Fadulu; Dong-Chuan Guo; Hariyadarshi Pannu; Hossein Golabbakhsh; Suzanne Smart; Julia H Chen; Sanjay Shete; Dong H Kim; Ralph Stern; Alan C Braverman; Dianna M Milewicz
Journal:  Am J Med Genet A       Date:  2011-08-03       Impact factor: 2.802

3.  Cerebral Aneurysms in Autosomal Dominant Polycystic Kidney Disease: A Comparison of Management Approaches.

Authors:  D Andrew Wilkinson; Michael Heung; Amrit Deol; Neeraj Chaudhary; Joseph J Gemmete; B Gregory Thompson; Aditya S Pandey
Journal:  Neurosurgery       Date:  2019-06-01       Impact factor: 4.654

4.  Canonical Wnt inhibitors ameliorate cystogenesis in a mouse ortholog of human ADPKD.

Authors:  Ao Li; Yuchen Xu; Song Fan; Jialin Meng; Xufeng Shen; Qian Xiao; Yuan Li; Li Zhang; Xiansheng Zhang; Guanqing Wu; Chaozhao Liang; Dianqing Wu
Journal:  JCI Insight       Date:  2018-03-08

Review 5.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

Review 6.  [What is evidence-based in the treatment of autosomal dominant polycystic kidney disease?]

Authors:  Vera Christine Wulfmeyer; Roland Schmitt
Journal:  Internist (Berl)       Date:  2021-10-28       Impact factor: 0.743

7.  Impaired Hedgehog-Gli1 Pathway Activity Underlies the Vascular Phenotype of Polycystic Kidney Disease.

Authors:  Federico Franchi; Karen M Peterson; Katherine Quandt; David Domnick; Timothy L Kline; Michaela Olthoff; Mojtaba Parvizi; Ezequiel J Tolosa; Vicente E Torres; Peter C Harris; Martin E Fernandez-Zapico; Martin G Rodriguez-Porcel
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

Review 8.  A polycystin-centric view of cyst formation and disease: the polycystins revisited.

Authors:  Albert C M Ong; Peter C Harris
Journal:  Kidney Int       Date:  2015-07-22       Impact factor: 10.612

9.  Rapamycin treatment dose-dependently improves the cystic kidney in a new ADPKD mouse model via the mTORC1 and cell-cycle-associated CDK1/cyclin axis.

Authors:  Ao Li; Song Fan; Yuchen Xu; Jialin Meng; Xufeng Shen; Jun Mao; Li Zhang; Xiansheng Zhang; Gilbert Moeckel; Dianqing Wu; Guanqing Wu; Chaozhao Liang
Journal:  J Cell Mol Med       Date:  2017-02-28       Impact factor: 5.310

Review 10.  Genetic associations of intracranial aneurysm formation and sub-arachnoid hemorrhage.

Authors:  Christian B Theodotou; Brian M Snelling; Samir Sur; Diogo C Haussen; Eric C Peterson; Mohamed Samy Elhammady
Journal:  Asian J Neurosurg       Date:  2017 Jul-Sep
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.